Macrogenics (MGNX) Other Accumulated Expenses (2013 - 2019)
Macrogenics' (MGNX) quarterly Other Accumulated Expenses came in at $175000.0 in Q3 2019, little changed year-on-year from $175000.0 in Q3 2018, and little changed on a QoQ basis from $175000.0 in Q2 2019.
Macrogenics (MGNX) Other Accumulated Expenses (2013 - 2019) Analysis & Trends
Macrogenics (MGNX) has 6 years of Other Accumulated Expenses data on file, last reported at $175000.0 in Q3 2019.
- On a quarterly basis, Other Accumulated Expenses changed 0.0% year-over-year to $175000.0 in Q3 2019; TTM through Sep 2019 was $175000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $175000.0, down 63.0% from the prior year.
- Other Accumulated Expenses for Q3 2019 stood at $175000.0, roughly flat from $175000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for MGNX reached as high as $1.6 million in Q1 2015 and fell as low as $175000.0 in Q3 2017.
- Historically, Other Accumulated Expenses has averaged $570384.6 across 4 years, with a median of $175000.0 in 2017.
- Across the five-year window, Other Accumulated Expenses soared 342.25% in 2015 and tumbled 63.0% in 2018, its largest moves.
- Year by year, Other Accumulated Expenses stood at $727000.0 in 2015, then sank by 34.94% to $473000.0 in 2017, then tumbled by 63.0% to $175000.0 in 2018, then changed by 0.0% to $175000.0 in 2019.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $175000.0 in Q3 2019, $175000.0 in Q2 2019, and $175000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 175,000.00 |
| Jun 30, 2019 | 175,000.00 |
| Mar 31, 2019 | 175,000.00 |
| Dec 31, 2018 | 175,000.00 |
| Sep 30, 2018 | 175,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 175,000.00 |
| Dec 31, 2017 | 473,000.00 |
| Sep 30, 2017 | 175,000.00 |
| Dec 31, 2015 | 727,000.00 |
| Sep 30, 2015 | 1.61 Mn |
| Jun 30, 2015 | 1.61 Mn |
| Mar 31, 2015 | 1.61 Mn |
| Dec 31, 2014 | 1.61 Mn |
| Sep 30, 2014 | 363,000.00 |
| Jun 30, 2014 | 363,000.00 |
| Mar 31, 2014 | 362,920.00 |
| Dec 31, 2013 | 363,000.00 |